Abstract
The development of a reticulum cell sarcoma in the lung of a patient with systemic lupus erythematosus treated with azathioprine for 18 months is described. This possible hazard of immunosuppressive therapy is discussed in relation to patients with SLE.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Casey T. P. Azathioprine administration to NZB X NZW hybrid mice with lupus nephritis: beneficial effect complicated by development of malignant lymphomas. N Z Med J. 1973 Oct 10;79(500):290–295. [PubMed] [Google Scholar]
- Goldenberg G. J., Paraskevas F., Israels L. G. Lymphocyte and plasma cell neoplasms associated with autoimmune diseases. Semin Arthritis Rheum. 1971 Aug;1(2):174–193. doi: 10.1016/0049-0172(71)90005-9. [DOI] [PubMed] [Google Scholar]
- Hoover R., Fraumeni J. F., Jr Risk of cancer in renal-transplant recipients. Lancet. 1973 Jul 14;2(7820):55–57. doi: 10.1016/s0140-6736(73)93256-x. [DOI] [PubMed] [Google Scholar]
- Lipsmeyer E. A. Development of malignant cerebral lymphoma in a patient with systemic lupus erythematosus treated with immunosuppression. Arthritis Rheum. 1972 Mar-Apr;15(2):183–186. doi: 10.1002/art.1780150207. [DOI] [PubMed] [Google Scholar]